HMPL-A580
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HMPL-A580, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor [Phase 1, Phase 2]